Venous Thromboembolism in Hospitalized Patients With COVID-19 Receiving Prophylactic Anticoagulation

Mayo Clin Proc. 2020 Oct;95(10):2291-2293. doi: 10.1016/j.mayocp.2020.08.014. Epub 2020 Aug 13.

Authors

Romsai T Boonyasai¹, Vivek Krishna Murthy², Gigi Yuen-Gee Liu², Brian T Garibaldi², Daniel J Brotman², Michael B Streiff², Rodney Omron³

Affiliations

¹ Department of Medicine, Johns Hopkins University School of Medicine, Baltimore, MD; Department of Health Policy and Management, Johns Hopkins Bloomberg School of Public Health, Baltimore, MD.
² Department of Medicine, Johns Hopkins University School of Medicine, Baltimore, MD.
³ Department of Emergency Medicine, Johns Hopkins University School of Medicine, Baltimore, MD.

No abstract available

Publication types

Case Reports
Letter

MeSH terms

Adult
Anticoagulants / therapeutic use*
Betacoronavirus*
COVID-19
Coronavirus Infections / complications*
Coronavirus Infections / physiopathology
Critical Illness / therapy*
Humans
Intensive Care Units
Male
Middle Aged
Pandemics
Pneumonia, Viral / complications*
Pneumonia, Viral / physiopathology
Premedication / methods
Risk Assessment
SARS-CoV-2
Severity of Illness Index
Venous Thromboembolism / drug therapy*
Venous Thromboembolism / etiology*

Substances

Anticoagulants